On the other hand, as a serial acquirer, if Valeant simply adds Medicis, and then looks for its next deal without taking care to truly integrate Medicis and manage it well, this could turn out to be a benefit to competitors like Allergan.
FORBES: Valeant To Acquire Medicis for $2.6 Billion